Tecrea officially became a member of the four-year European Marie Curie IAPP project, DNA Trap, which began in October 2013. This project is designed to facilitate the exchange of knowledge and technology between 2 leading European research organisations (Procarta Biosystems in Norwich,UK and CSGI in Florence, Italy) and 4 SMEs (Small and Medium Enterprises).
DNA-TRAP is developing novel, oligonucleotide-based therapeutics, that are active against resistant strains. These are encapsulated in a nanoparticle (NP) uniquely capable of delivering the oligonucleotide to a wide range of bacteria – to the cytoplasm – where it interferes with transcription & prevents growth of the pathogen. The process targets two superbugs: Clostridium difficile infection & respiratory infections caused by Gram-negative agents such as Pseudomonas aeruginosa.
To learn more about the project, you can visit the website : http://dnatrap-iapp.eu/